NURS 5432 MODULE 4 — 2026 MEN’S HEALTH
COMPLETE (100) CURRENT TESTING QUESTIONS
AND CORRECT ANSWERS WITH DETAILED
RATIONALES.
NURS
Prepare with confidence using this NURS 5432 Module 4 — Men’s Health,
designed to assess key concepts in male health and wellness. It focuses on
reproductive health, common male conditions, screening guidelines, hormonal
disorders, and preventive care. The material strengthens clinical reasoning and
patient-centered management strategies. Suitable for graduate nursing and
healthcare students preparing for exams and clinical practice.
Multiple choice.
Section 4: NURS 5432 Module 4 — Men's Health (Questions 1–100)
Subsection 4.1: Benign Prostatic Hyperplasia (BPH) – Questions 1–
15
1. A 55-year-old male presents with a gradual decrease in urine
stream strength, hesitancy, and nocturia twice per night. His post-
void residual is 80 mL. What is the most likely diagnosis?
A. Acute prostatitis
B. Benign prostatic hyperplasia (BPH)
C. Prostate cancer
D. Urethral stricture
Answer: B. Benign prostatic hyperplasia (BPH)
Explanation: BPH typically presents with lower urinary tract
symptoms (LUTS) including weak stream, hesitancy, and nocturia in
older men.
2. Which medication class is considered first-line therapy for
symptomatic BPH in men with an enlarged prostate?
, Page 2 of 35
A. 5-alpha reductase inhibitors
B. Alpha-1 adrenergic receptor antagonists
C. Anticholinergics
D. Phosphodiesterase-5 inhibitors
Answer: B. Alpha-1 adrenergic receptor antagonists
Explanation: Alpha blockers relax smooth muscle in the prostate and
bladder neck, providing rapid symptom relief.
3. A 68-year-old male with BPH has an IPSS score of 22 (severe
symptoms). He tries tamsulosin for 4 weeks with minimal
improvement. What is the next best step?
A. Add finasteride
B. Switch to silodosin
C. Refer for surgical evaluation (TURP)
D. Increase tamsulosin dose
Answer: A. Add finasteride
Explanation: For men with large prostates (>40 mL) and severe
symptoms, combination therapy (alpha blocker + 5-alpha reductase
inhibitor) is superior to monotherapy. Surgery is reserved for
medication failure or complications.
4. Which of the following is a contraindication to using finasteride
for BPH?
A. Age >70
B. History of prostate cancer
C. PSA >10 ng/mL without biopsy
D. Sexual dysfunction
Answer: C. PSA >10 ng/mL without biopsy
Explanation: Finasteride lowers PSA by ~50%. An elevated PSA
(>10) before starting finasteride warrants urology referral and
biopsy to rule out prostate cancer before treatment.
5. A 72-year-old male with BPH on doxazosin presents with
dizziness when standing up from a seated position. What is the
most likely cause?
, Page 3 of 35
A. Allergic reaction
B. Orthostatic hypotension from alpha blockade
C. Acute kidney injury
D. Urinary tract infection
Answer: B. Orthostatic hypotension from alpha blockade
Explanation: Alpha blockers (especially non-selective like doxazosin)
can cause vasodilation and orthostatic hypotension. Tamsulosin is
more uroselective with fewer blood pressure effects.
6. What is the most common complication of untreated BPH?
A. Prostate cancer
B. Acute urinary retention
C. Erectile dysfunction
D. Chronic kidney disease
Answer: B. Acute urinary retention
Explanation: Acute urinary retention is the most common
complication. Chronic kidney disease can occur but is less common if
obstruction is not severe.
7. A 65-year-old male with BPH reports taking saw palmetto for 6
months with no improvement. What should the nurse practitioner
advise?
A. Continue saw palmetto and add tamsulosin
B. Discontinue saw palmetto and consider evidence-based medical
therapy
C. Increase saw palmetto dose
D. Refer for immediate surgery
Answer: B. Discontinue saw palmetto and consider evidence-based
medical therapy
Explanation: Saw palmetto has not shown consistent benefit over
placebo in clinical trials. Discontinue ineffective supplements and
start guideline-directed medical therapy.
8. Which finding on digital rectal exam (DRE) is most consistent
with BPH rather than prostate cancer?
, Page 4 of 35
A. Hard, irregular nodule
B. Symmetrically enlarged, smooth, firm prostate
C. Boggy, tender prostate
D. Non-palpable prostate
Answer: B. Symmetrically enlarged, smooth, firm prostate
Explanation: BPH typically presents as a symmetrically enlarged,
smooth, rubbery prostate. Prostate cancer often feels hard, irregular,
or nodular.
9. A patient asks how long it takes for finasteride to reduce
prostate size and improve symptoms. What is the correct
response?
A. 1–2 days
B. 2–4 weeks
C. 3–6 months
D. 12–18 months
Answer: C. 3–6 months
Explanation: 5-alpha reductase inhibitors reduce DHT levels, causing
prostate shrinkage over 3–6 months. Symptom improvement lags
behind alpha blockers.
10. A 70-year-old male with BPH has a PSA of 1.2 ng/mL while on
finasteride for 2 years. What is the appropriate interpretation?
A. PSA is falsely low; multiply by 2 for true value
B. PSA is normal; no further action
C. PSA is elevated for a patient on finasteride
D. Discontinue finasteride and repeat PSA
Answer: B. PSA is normal; no further action
Explanation: On finasteride, PSA is multiplied by 2 to estimate non-
treated value (1.2 × 2 = 2.4, still normal). No urgent action needed.
11. Which of the following is an absolute indication for surgical
intervention in BPH?
A. Nocturia twice per night
B. Recurrent urinary retention